Literature DB >> 23990135

Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011.

D Bhattacharya1, H Bhattacharya, R Thamizhmani, D S Sayi, R Reesu, M Anwesh, C Kartick, A P Bharadwaj, M Singhania, A P Sugunan, S Roy.   

Abstract

This study aims to determine the clinical features and seasonal patterns associated with shigellosis, the antimicrobial resistance frequencies of the isolates obtained during the period 2006-2012 for 22 antibiotics, and the molecular characterization of multidrug-resistant strains isolated from endemic cases of shigellosis in the remote islands of India, with special reference to fluoroquinolone and third-generation cephalosporins resistance. During the period from January 2006 to December 2011, stool samples were obtained and processed to isolate Shigella spp. The isolates were evaluated with respect to their antibiotic resistance pattern and various multidrug resistance determinants, including resistance genes, quinolone resistance determinants, and extended-spectrum β-lactamase (ESBL) production. Morbidity for shigellosis was found to be 9.3 % among children in these islands. Cases of shigellosis occurred mainly during the rainy seasons and were found to be higher in the age group 2-5 years. A wide spectrum of resistance was observed among the Shigella strains, and more than 50 % of the isolates were multidrug-resistant. The development of multidrug-resistant strains was found to be associated with various drug-resistant genes, multiple mutations in the quinolone resistance-determining region (QRDR), and the presence of plasmid-mediated quinolone-resistant determinants and efflux pump mediators. This report represents the first presentation of the results of long-term surveillance and molecular characterization concerning antimicrobial resistances in clinical Shigella strains in these islands. Information gathered as part of the investigations will be instrumental in identifying emerging antimicrobial resistance, for developing treatment guidelines appropriate for that community, and to provide baseline data with which to compare outbreak strains in the future.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23990135     DOI: 10.1007/s10096-013-1937-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  39 in total

1.  Shigellosis: disease burden, epidemiology and case management.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2005-03-18

Review 2.  Molecular mechanisms of antibacterial multidrug resistance.

Authors:  Michael N Alekshun; Stuart B Levy
Journal:  Cell       Date:  2007-03-23       Impact factor: 41.582

3.  Antimicrobial resistance of Shigella sonnei in Korea during the last two decades.

Authors:  J C Lee; J Y Oh; K S Kim; Y W Jeong; J W Cho; J C Park; S Y Seol; D T Cho
Journal:  APMIS       Date:  2001-03       Impact factor: 3.205

4.  Existing status of shigellosis in Andaman & Nicobar islands.

Authors:  A R Ghosh; S C Sehgal
Journal:  Indian J Med Res       Date:  1996-03       Impact factor: 2.375

5.  The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori.

Authors:  T Falsafi; A Ehsani; V Niknam
Journal:  Indian J Med Microbiol       Date:  2009 Oct-Dec       Impact factor: 0.985

6.  Genetic characterization of multidrug resistance in Shigella spp. from Japan.

Authors:  Ashraf M Ahmed; Kimi Furuta; Kei Shimomura; Yoshio Kasama; Tadashi Shimamoto
Journal:  J Med Microbiol       Date:  2006-12       Impact factor: 2.472

7.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

8.  Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals.

Authors:  Laura Briñas; Myriam Zarazaga; Yolanda Sáenz; Fernanda Ruiz-Larrea; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

9.  Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India.

Authors:  Gururaja Perumal Pazhani; Swapan Kumar Niyogi; Anil Kumar Singh; Bhaswati Sen; Neelam Taneja; Manikuntala Kundu; Shinji Yamasaki; Thandavarayan Ramamurthy
Journal:  J Med Microbiol       Date:  2008-07       Impact factor: 2.472

10.  Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period.

Authors:  Hong Bin Kim; Chi Hye Park; Chung Jong Kim; Eui-Chong Kim; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

View more
  17 in total

1.  Case of Shigella flexneri infection with treatment failure due to azithromycin resistance in an HIV-positive patient.

Authors:  R-J Hassing; D C Melles; W H F Goessens; B J A Rijnders
Journal:  Infection       Date:  2014-02-02       Impact factor: 3.553

Review 2.  Shigella flexneri: an emerging pathogen.

Authors:  Iqbal Nisa; Muhammad Qasim; Nusrat Yasin; Rafi Ullah; Anwar Ali
Journal:  Folia Microbiol (Praha)       Date:  2020-02-05       Impact factor: 2.099

3.  Diarrhegenic Escherichia coli Replaces Shigella spp. as the Predominant Bacteria Causing Childhood Diarrhea in Andaman and Nicobar Islands, India.

Authors:  P Ramya Raghavan; Sugunan Attayoor Purushothaman; Thamizhmani Ramanathan; Subarna Roy
Journal:  Am J Trop Med Hyg       Date:  2018-01-18       Impact factor: 2.345

4.  In Vitro Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin.

Authors:  George P Allen; Kayla A Harris
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

5.  Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance.

Authors:  Carlos Toro; Ana Arroyo; Ana Sarria; Nuria Iglesias; Ana Enríquez; Margarita Baquero; Concepción Ladrón de Guevara
Journal:  Am J Trop Med Hyg       Date:  2015-07-20       Impact factor: 2.345

6.  Burden, Antibiotic Resistance, and Clonality of Shigella spp. Implicated in Community-Acquired Acute Diarrhoea in Lilongwe, Malawi.

Authors:  Abel F N D Phiri; Akebe Luther King Abia; Daniel Gyamfi Amoako; Rajab Mkakosya; Arnfinn Sundsfjord; Sabiha Y Essack; Gunnar Skov Simonsen
Journal:  Trop Med Infect Dis       Date:  2021-04-28

7.  Changing patterns and widening of antibiotic resistance in Shigella spp. over a decade (2000-2011), Andaman Islands, India.

Authors:  D Bhattacharya; H Bhattacharya; D S Sayi; A P Bharadwaj; M Singhania; A P Sugunan; S Roy
Journal:  Epidemiol Infect       Date:  2014-04-24       Impact factor: 4.434

8.  Isolation of NDM-1-producing multidrug-resistant Pseudomonas putida from a paediatric case of acute gastroenteritis, India.

Authors:  D Bhattacharya; S Dey; S Kadam; S Kalal; S Jali; H Koley; R Sinha; D Nag; S D Kholkute; S Roy
Journal:  New Microbes New Infect       Date:  2015-02-28

9.  The Emergence of Quinolone Resistant Shigella sonnei, Pondicherry, India.

Authors:  Ankita Das; Mailan Natarajan; Jharna Mandal
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

Review 10.  Shigellosis: Epidemiology in India.

Authors:  Neelam Taneja; Abhishek Mewara
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.